REQUEST A DEMO
Total
USD $0.00
Search more companies

Ramedicas S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ramedicas S.A.S. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ramedicas S.A.S. is a company in Colombia, with a head office in Bucaramanga. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on November 12, 2020. The total number of employees is currently 180 (2024). The latest financial highlights indicate a net sales revenue increase of 26.57% in 2023. Its’ total assets recorded a growth of 38.21%. The net profit margin of Ramedicas S.A.S. increased by 0.19% in 2023.

Headquarters
Carrera 31 W No.71-70 Bodega 4
Bucaramanga; Santander;

Contact Details: Purchase the Ramedicas S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Ramedicas S.A.S. report to view the information.
Outstanding Shares:
Purchase the Ramedicas S.A.S. report to view the information.
Incorporation Date:
November 12, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Ramedicas S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
26.57%
Total operating revenue
26.57%
Net Profit (Loss) for the Period
30.65%
Total assets
38.21%
Total equity
72.74%
Net Profit Margin
0.19%
Return on Equity (ROE)
-11.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?